Breaks Categories: News

ThursdayAug 15, 2019 10:15 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Four New Patents, Increasing Total Granted to 15

Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the granting of four of its pending patent applications via its wholly-owned subsidiary Poviva Corp. According to the update, the new patents cover delivery of cannabinoids such as THC and CBD, NSAIDs such as ibuprofen, nicotine, and vitamins. With issuance of these four patents, Lexaria’s total patents granted has increased to 15, with eight in the US and seven in Australia, and the company has roughly 60 patent applications pending throughout the world. Lexaria is one of the most patent-rich firms in the Western…

Continue Reading

WednesdayAug 14, 2019 12:43 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Appoints Consumer Packaged Goods Veteran to Board of Directors

Biotechnology company and global drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced the appointment of Brian Quigley to its board of directors. Quigley most recently spent 16 years at Altria Group, seven of which were spent as president and CEO for U.S. Smokeless Tobacco and Nu-Mark, Altria's innovation company, during the time that the existing Lexaria and Altria business relationship was negotiated. Quigley is a 20-year Consumer Packaged Goods veteran with a background of managing complex regulatory environments including for novel and innovative nicotine products, and holds additional deep experience with operations and marketing. “Lexaria continues…

Continue Reading

WednesdayAug 14, 2019 11:48 am

CannabisNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Enters Definitive Agreement with SolDaze

TransCanna Holdings (CSE: TCAN) (FSE: TH8) this morning announced its entry into a definitive purchase agreement for all of the outstanding equity interest in Tres Ojos Naturals LLC, doing business as SolDaze, a Santa Cruz, California-based limited liability company. Per the update, the transaction will absorb SolDaze's branding asset package into the company's expanding asset portfolio, providing what it believes will be significant penetration into the cannabis market in California. “We are very pleased and excited to welcome the SolDaze team into the TransCanna family. We would like to recognize their efforts, achievements and in particular their patience and dedication…

Continue Reading

WednesdayAug 14, 2019 11:02 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Q2 2019 Results

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) on Tuesday released its financial and operational results for the three and six months ended June 30, 2019. In addition, TGODF management hosted a call to discuss the results at 9:00 AM ET on August 14, 2019, and a playback is available for approximately one week at http://cnw.fm/q2yuH. “Q2 was pivotal for the Company as we began commercial production in the second phase of our Hamilton site and expanded our product line for the Grower's Circle,” TGOD CEO Brian Athaide said in the news release. “The…

Continue Reading

WednesdayAug 14, 2019 10:52 am

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Closing of Truverra Inc. Acquisition

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Tuesday announced the closing of its acquisition of all of the issued and outstanding shares of privately-held Truverra Inc. According to the update, the transaction was completed by way of a three-cornered amalgamation. 2708300 Ontario Ltd., a wholly-owned subsidiary of Supreme Cannabis, combined with Truverra to form a newly amalgamated company that will operate under the name "Truverra Inc." as a wholly-owned subsidiary of the company. Consideration for the transaction, which was previously announced by Supreme Cannabis on July 17, 2019, consisted of the issuance of approximately 14.7 million common…

Continue Reading

WednesdayAug 14, 2019 9:57 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) to Release Q1 Fiscal Year 2020 Financial Results and Host Earnings Call

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced its plans to report first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. According to the update, Canopy Rivers will host a conference call and audio webcast following release of its results. The company’s president and CEO Narbe Alexandrian and CFO Eddie Lucarelli will lead the call, slated to be held at 10:00 AM ET on August 27, 2019. Interested parties may register for and join the live audio webcast at http://cnw.fm/bn3YI and join the call by dialing (888)-390-0546. A replay of the call will…

Continue Reading

TuesdayAug 13, 2019 9:49 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Subsidiary Receives Health Canada Cannabis R&D License

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that Health Canada has issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 to its subsidiary, Lexaria CanPharm ULC. According to the update, the license, which carries a four-year term unless renewed, is effective immediately and will allow one of the country’s newest and most advanced formulation laboratories to conduct extensive investigatory work in THC and CBD delivery using optimized, proprietary formulations and techniques. The purpose-built laboratory is permitted at local and federal levels and fully outfitted to produce DehydraTECH(TM) infusions and includes two different…

Continue Reading

TuesdayAug 13, 2019 9:30 am

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expects Positive Q4 Results, Provides Guidance for Fiscal 2020

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) this morning announced its projected revenue for the fiscal fourth quarter ended June 30, 2019 and provided guidance for fiscal 2020. Per the update, the company anticipates net revenue of about $19 million and positive adjusted EBITDA for the fourth quarter 2019. Supreme Cannabis also expects sustained revenue growth during 2020 as its wholly owned subsidiary 7ACRES scales production, new and higher-margin products are introduced, and additional brands start producing material revenue. The company plans to release audited fourth quarter and annual results on September 17, 2019. “Our company has taken…

Continue Reading

MondayAug 12, 2019 1:14 pm

CannabisNewsBreaks – Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) City Cannabis Opens Two New Premier Cannabis Retail Locations in Cultured BC Market

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) this morning announced that British Columbia’s Liquor and Cannabis Regulation Branch has issued a Cannabis Retail Store license to City Cannabis Co’s 2317 Cambie Street location and its Comox Valley location on Vancouver Island. Wildflower recently acquired City Cannabis Co, which, with its third and fourth locations in the province, is at the forefront of the BC retail cannabis market. “City Cannabis Co’s experience and history of operations for over five years in the most cultured cannabis market in the world has allowed them to accumulate priceless data that has been used to…

Continue Reading

MondayAug 12, 2019 12:33 pm

CannabisNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters Definitive Agreement to Acquire Vertically Integrated Assets in Arizona

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced its entry into a definitive agreement for the acquisition of 100 percent of the membership units of a licensed medical marijuana business in the state of Arizona (“The Asset”). The Asset, according to the update, is licensed under the provisions of the Arizona Medical Marijuana Act and operates a dispensary in Phoenix, which has been operational since 2015 with proprietary branded products and wholesale operations, including an established distribution network serving more than…

Continue Reading